Clinical trial
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be…
NCT00004254 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00004254 |
|---|---|
| Title | Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed |
| Official title | Phase II Study on Tomusex in Malignant Mesothelioma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Mesothelioma |
| Intervention type | Drug |
| Interventions | raltitrexed |
| Enrollment | 25 |
| Start date | Nov 1, 1999 |
| Primary completion | Jun 1, 2001 |
| First posted | Apr 23, 2004 |
| Last update posted | Jul 18, 2012 |
| Countries | Italy, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: